Hypoxia and local inflammation in pulmonary artery structure and function

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hypoxia is recognized as a contributor to pulmonary vascular diseases such as pulmonary hypertension. Hypoxia-induced inflammatory changes can enhance structural and functional changes in pulmonary artery (PA) in the context of PH. Accordingly, understanding how hypoxia and inflammation are linked in the context of pulmonary artery structure and function could be relevant towards development of novel therapies for PH. In this regard, factors such as thymic stromal lymphopoietin (TSLP), an inflammatory cytokine, and brain-derived neurotrophic factor (BDNF), a neurotrophin, have been found critical for nonvascular systems such as airway and asthma. While TSLP canonically affects the immune system, in nonvascular systems, noncanonical effects such as altered [Ca2+]i and cell proliferation have been noted: aspects also relevant to the PA, where there is currently little to no data. Similarly, better known in the nervous system, there is increasing evidence that BDNF is locally produced by structural cells of the airway and can contribute to asthma pathophysiology. In this chapter, we summarize the potential relevance of factors such as TSLP and BDNF to the PA and in the context of hypoxia influences towards development of PH. We focus on cell sources and targets such as PA endothelial cells (PAECs) and smooth muscle cells (PASMCs), and the effects of TSLP or BDNF on intracellular Ca2+ responses to vasoconstrictor agonist, cell proliferation, and potential signaling cascades involved.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages325-334
Number of pages10
Volume967
DOIs
StatePublished - 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume967
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Brain-Derived Neurotrophic Factor
Pulmonary Artery
Inflammation
Cell proliferation
Asthma
Cell Proliferation
Immune system
Endothelial cells
Nerve Growth Factors
Neurology
Vasoconstrictor Agents
Muscle
Vascular Diseases
Pulmonary Hypertension
Nervous System
Cells
Lung Diseases
Smooth Muscle Myocytes
Cytokines
Immune System

Keywords

  • Brain-derived neurotrophic factor
  • Calcium signaling
  • Endothelial cells
  • Hypoxia
  • Pulmonary vascular disease
  • Reactive oxygen species
  • Smooth muscle cells
  • Thymic stromal lymphopoietin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Thompson, M., Britt, R. J., Pabelick, C. M., & Prakash, Y. S. (2017). Hypoxia and local inflammation in pulmonary artery structure and function. In Advances in Experimental Medicine and Biology (Vol. 967, pp. 325-334). (Advances in Experimental Medicine and Biology; Vol. 967). Springer New York LLC. https://doi.org/10.1007/978-3-319-63245-2_20

Hypoxia and local inflammation in pulmonary artery structure and function. / Thompson, Michael; Britt, Rodney Jr.; Pabelick, Christina M; Prakash, Y.s.

Advances in Experimental Medicine and Biology. Vol. 967 Springer New York LLC, 2017. p. 325-334 (Advances in Experimental Medicine and Biology; Vol. 967).

Research output: Chapter in Book/Report/Conference proceedingChapter

Thompson, M, Britt, RJ, Pabelick, CM & Prakash, YS 2017, Hypoxia and local inflammation in pulmonary artery structure and function. in Advances in Experimental Medicine and Biology. vol. 967, Advances in Experimental Medicine and Biology, vol. 967, Springer New York LLC, pp. 325-334. https://doi.org/10.1007/978-3-319-63245-2_20
Thompson M, Britt RJ, Pabelick CM, Prakash YS. Hypoxia and local inflammation in pulmonary artery structure and function. In Advances in Experimental Medicine and Biology. Vol. 967. Springer New York LLC. 2017. p. 325-334. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-63245-2_20
Thompson, Michael ; Britt, Rodney Jr. ; Pabelick, Christina M ; Prakash, Y.s. / Hypoxia and local inflammation in pulmonary artery structure and function. Advances in Experimental Medicine and Biology. Vol. 967 Springer New York LLC, 2017. pp. 325-334 (Advances in Experimental Medicine and Biology).
@inbook{8f0de36fdd6c4f1c914684d514b69406,
title = "Hypoxia and local inflammation in pulmonary artery structure and function",
abstract = "Hypoxia is recognized as a contributor to pulmonary vascular diseases such as pulmonary hypertension. Hypoxia-induced inflammatory changes can enhance structural and functional changes in pulmonary artery (PA) in the context of PH. Accordingly, understanding how hypoxia and inflammation are linked in the context of pulmonary artery structure and function could be relevant towards development of novel therapies for PH. In this regard, factors such as thymic stromal lymphopoietin (TSLP), an inflammatory cytokine, and brain-derived neurotrophic factor (BDNF), a neurotrophin, have been found critical for nonvascular systems such as airway and asthma. While TSLP canonically affects the immune system, in nonvascular systems, noncanonical effects such as altered [Ca2+]i and cell proliferation have been noted: aspects also relevant to the PA, where there is currently little to no data. Similarly, better known in the nervous system, there is increasing evidence that BDNF is locally produced by structural cells of the airway and can contribute to asthma pathophysiology. In this chapter, we summarize the potential relevance of factors such as TSLP and BDNF to the PA and in the context of hypoxia influences towards development of PH. We focus on cell sources and targets such as PA endothelial cells (PAECs) and smooth muscle cells (PASMCs), and the effects of TSLP or BDNF on intracellular Ca2+ responses to vasoconstrictor agonist, cell proliferation, and potential signaling cascades involved.",
keywords = "Brain-derived neurotrophic factor, Calcium signaling, Endothelial cells, Hypoxia, Pulmonary vascular disease, Reactive oxygen species, Smooth muscle cells, Thymic stromal lymphopoietin",
author = "Michael Thompson and Britt, {Rodney Jr.} and Pabelick, {Christina M} and Y.s. Prakash",
year = "2017",
doi = "10.1007/978-3-319-63245-2_20",
language = "English (US)",
volume = "967",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "325--334",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Hypoxia and local inflammation in pulmonary artery structure and function

AU - Thompson, Michael

AU - Britt, Rodney Jr.

AU - Pabelick, Christina M

AU - Prakash, Y.s.

PY - 2017

Y1 - 2017

N2 - Hypoxia is recognized as a contributor to pulmonary vascular diseases such as pulmonary hypertension. Hypoxia-induced inflammatory changes can enhance structural and functional changes in pulmonary artery (PA) in the context of PH. Accordingly, understanding how hypoxia and inflammation are linked in the context of pulmonary artery structure and function could be relevant towards development of novel therapies for PH. In this regard, factors such as thymic stromal lymphopoietin (TSLP), an inflammatory cytokine, and brain-derived neurotrophic factor (BDNF), a neurotrophin, have been found critical for nonvascular systems such as airway and asthma. While TSLP canonically affects the immune system, in nonvascular systems, noncanonical effects such as altered [Ca2+]i and cell proliferation have been noted: aspects also relevant to the PA, where there is currently little to no data. Similarly, better known in the nervous system, there is increasing evidence that BDNF is locally produced by structural cells of the airway and can contribute to asthma pathophysiology. In this chapter, we summarize the potential relevance of factors such as TSLP and BDNF to the PA and in the context of hypoxia influences towards development of PH. We focus on cell sources and targets such as PA endothelial cells (PAECs) and smooth muscle cells (PASMCs), and the effects of TSLP or BDNF on intracellular Ca2+ responses to vasoconstrictor agonist, cell proliferation, and potential signaling cascades involved.

AB - Hypoxia is recognized as a contributor to pulmonary vascular diseases such as pulmonary hypertension. Hypoxia-induced inflammatory changes can enhance structural and functional changes in pulmonary artery (PA) in the context of PH. Accordingly, understanding how hypoxia and inflammation are linked in the context of pulmonary artery structure and function could be relevant towards development of novel therapies for PH. In this regard, factors such as thymic stromal lymphopoietin (TSLP), an inflammatory cytokine, and brain-derived neurotrophic factor (BDNF), a neurotrophin, have been found critical for nonvascular systems such as airway and asthma. While TSLP canonically affects the immune system, in nonvascular systems, noncanonical effects such as altered [Ca2+]i and cell proliferation have been noted: aspects also relevant to the PA, where there is currently little to no data. Similarly, better known in the nervous system, there is increasing evidence that BDNF is locally produced by structural cells of the airway and can contribute to asthma pathophysiology. In this chapter, we summarize the potential relevance of factors such as TSLP and BDNF to the PA and in the context of hypoxia influences towards development of PH. We focus on cell sources and targets such as PA endothelial cells (PAECs) and smooth muscle cells (PASMCs), and the effects of TSLP or BDNF on intracellular Ca2+ responses to vasoconstrictor agonist, cell proliferation, and potential signaling cascades involved.

KW - Brain-derived neurotrophic factor

KW - Calcium signaling

KW - Endothelial cells

KW - Hypoxia

KW - Pulmonary vascular disease

KW - Reactive oxygen species

KW - Smooth muscle cells

KW - Thymic stromal lymphopoietin

UR - http://www.scopus.com/inward/record.url?scp=85031999848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031999848&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-63245-2_20

DO - 10.1007/978-3-319-63245-2_20

M3 - Chapter

C2 - 29047096

AN - SCOPUS:85031999848

VL - 967

T3 - Advances in Experimental Medicine and Biology

SP - 325

EP - 334

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -